Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jul. 31, 2025
Jul. 31, 2024
Jul. 31, 2025
Jul. 31, 2024
Income Statement [Abstract]        
Revenue
Operating expenses:        
Research and development expenses (including non-cash stock-based compensation expenses of $358, $462, $1,172 and $1,471, respectively) 1,055 1,925 3,929 4,920
General and administrative expenses (including non-cash stock-based compensation expenses of $497, $717, $1,727 and $2,228, respectively) 1,381 1,667 4,896 5,748
Total operating expenses 2,436 3,592 8,825 10,668
Loss from operations (2,436) (3,592) (8,825) (10,668)
Interest income 156 277 519 883
Net loss (2,280) (3,315) (8,306) (9,785)
Less: Net loss attributable to noncontrolling interest (22) (38) (74) (114)
Net loss attributable to common shareholders $ (2,258) $ (3,277) $ (8,232) $ (9,671)
Net loss per common share attributable to common shareholders:        
Basic $ (0.07) $ (0.10) $ (0.25) $ (0.30)
Diluted $ (0.07) $ (0.10) $ (0.25) $ (0.30)
Weighted average common shares outstanding:        
Basic 32,476 32,054 32,293 31,804
Diluted 32,476 32,054 32,293 31,804